Patent Assignment
Reel/Frame 050478/0629
RELEASE OF SECURITY INTEREST
Recorded: 2019-09-24
Received: 2019-09-24
Pages: 6
Assignor
CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Executed: 2019-09-24
Assignee
AEGERION PHARMACEUTICALS, INC.
ONE MAIN STREET, SUITE 800, CAMBRIDGE, MA, 02142, UNITED STATES
Covered Applications
(6)
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
App. No. 15/882,919
→
COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
App. No. 15/570,246
→
Methods of Detecting Anti-Leptin Neutralizing Antibodies
App. No. 15/702,719
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/837,705
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
App. No. 14/800,537
→
A CHIMERIC LEPTIN POLYPEPTIDE AND METHOD OF USING THE SAME
App. No. 14/703,523
→